Davenport Downgrades Orexigen Therapeutics (OREX) to Neutral

July 16, 2010 9:36 AM EDT Send to a Friend
Get Alerts OREX Hot Sheet
Price: $7.75 +2.79%

Rating Summary:
    10 Buy, 4 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 23 | New: 16
Trade OREX Now!
Join SI Premium – FREE
Davenport downgrades Orexigen Therapeutics (Nasdaq: OREX) from Buy to Neutral.

To see all the upgrades/downgrades on shares of OREX, visit our Analyst Ratings page.

Orexigen Therapeutics, Inc. (Orexigen) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment